Moxibustion Treatment, Alongside Conventional Western and Chinese Herbal Medical Therapies, May Improve Survival in Stage-IV Pulmonary Adenocarcinomas in a Dosage-Dependent Manner: A Prospective Observational Study With Propensity Score Analysis

Background: 25% to 30% of primary stage IV pulmonary adenocarcinomas (PUAD-IV) die within 3 months. Many ≥3 months survivors at long follow-up are alive with disease (AWD). Platinum-based chemotherapy (PBC), tyrosine kinase inhibitors- targeted therapy (TKI-TT), and Chinese herbal medicines (oral CH...

Descrición completa

Detalles Bibliográficos

Principais autores:	Hegen Li MD, Veronika Lindberg MSc, Lihua Zhu MD, PhD, Xiange Huang MD, Jiali Feng MD, Jan P. A. Baak MD, PhD, FICP, FRCPath, FIAC, DrHC(Antwerp), MScTCM
Formato:	Artigo
Idioma:	Inglês
Publicado:	SAGE Publishing 2025-06-01
Series:	Integrative Cancer Therapies
Acceso en liña:	https://doi.org/10.1177/15347354251342739
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!